Please use this identifier to cite or link to this item:
Title: Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development
Authors: Aswad, Luay
Yenamandra, Surya Pavan
Ow, Ghim Siong
Grinchuk, Oleg
Ivshina, Anna V.
Kuznetsov, Vladimir A.
Keywords: Invasive ductal carcinoma
Low and high genetic grades
Genome and transcriptome alterations
Oncogenic pathway
Issue Date: 2015
Source: Aswad, L., Yenamandra, S. P., Ow, G. S., Grinchuk, O., Ivshina, A. V., & Kuznetsov V. A. (2015). Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development. Oncotarget, 6(34), 36652-.
Series/Report no.: Oncotarget
Abstract: Invasive ductal carcinoma (IDC) is a major histo-morphologic type of breast cancer. Histological grading (HG) of IDC is widely adopted by oncologists as a prognostic factor. However, HG evaluation is highly subjective with only 50%–85% inter-observer agreements. Specifically, the subjectivity in the assignment of the intermediate grade (histologic grade 2, HG2) breast cancers (comprising ~50% of IDC cases) results in uncertain disease outcome prediction and sub-optimal systemic therapy. Despite several attempts to identify the mechanisms underlying the HG classification, their molecular bases are poorly understood. We performed integrative bioinformatics analysis of TCGA and several other cohorts (total 1246 patients). We identified a 22-gene tumor aggressiveness grading classifier (22g-TAG) that reflects global bifurcation in the IDC transcriptomes and reclassified patients with HG2 tumors into two genetically and clinically distinct subclasses: histological grade 1-like (HG1-like) and histological grade 3-like (HG3-like). The expression profiles and clinical outcomes of these subclasses were similar to the HG1 and HG3 tumors, respectively. We further reclassified IDC into low genetic grade (LGG = HG1+HG1-like) and high genetic grade (HGG = HG3-like+HG3) subclasses. For the HG1-like and HG3-like IDCs we found subclass-specific DNA alterations, somatic mutations, oncogenic pathways, cell cycle/mitosis and stem cell-like expression signatures that discriminate between these tumors. We found similar molecular patterns in the LGG and HGG tumor classes respectively. Our results suggest the existence of two genetically-predefined IDC classes, LGG and HGG, driven by distinct oncogenic pathways. They provide novel prognostic and therapeutic biomarkers and could open unique opportunities for personalized systemic therapies of IDC patients.
DOI: 10.18632/oncotarget.5543
Schools: School of Computer Engineering 
Rights: All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SCSE Journal Articles

Citations 20

Updated on Jun 19, 2024

Web of ScienceTM
Citations 20

Updated on Oct 30, 2023

Page view(s) 50

Updated on Jun 20, 2024

Download(s) 20

Updated on Jun 20, 2024

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.